HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs.

Shi X, Tan Z, Sun G, Zeng H, Zhang X

Open source

DOI
10.1186/s40364-026-00990-4
Published
2026 Aug 24
Container
Biomarker research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s40364-026-00990-4,
  title = {HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs.},
  author = {Shi X and Tan Z and Sun G and Zeng H and Zhang X},
  year = {2026},
  journal = {Biomarker research},
  doi = {10.1186/s40364-026-00990-4},
  url = {https://doi.org/10.1186/s40364-026-00990-4}
}

RIS

TY  - JOUR
TI  - HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs.
AU  - Shi X
AU  - Tan Z
AU  - Sun G
AU  - Zeng H
AU  - Zhang X
PY  - 2026
JO  - Biomarker research
DO  - 10.1186/s40364-026-00990-4
UR  - https://doi.org/10.1186/s40364-026-00990-4
ER  - 

APA

X, S., Z, T., G, S., H, Z., & X, Z. (2026). HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs.. Biomarker research. https://doi.org/10.1186/s40364-026-00990-4

Source records